OCULAR THERAPEUTIX, INC Debt Securities, Available-for-sale
OCULAR THERAPEUTIX, INC (OCUL) had Debt Securities, Available-for-sale of $0 as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2018-03-08
- 2017-09-30: Debt Securities, Available-for-sale $0.00.
- 2017-06-30: Debt Securities, Available-for-sale $3.00M.
- 2017-03-31: Debt Securities, Available-for-sale $25.70M.
- 2016-12-31: Debt Securities, Available-for-sale $35.21M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.00M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $25.70M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $35.21M 10-K · filed 2018-03-08 |
| 2016-09-30 | $23.51M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $35.72M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $49.24M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $74.28M 10-K · filed 2017-03-10 |
| 2015-09-30 | $72.44M 10-Q · filed 2015-11-10 |
| 2015-06-30 | $45.04M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $54.90M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $37.44M 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |